...
首页> 外文期刊>Applied Microbiology and Biotechnology >Effects of polysaccharides from Morchella conica on nitric oxide production in lipopolysaccharide-treated macrophages
【24h】

Effects of polysaccharides from Morchella conica on nitric oxide production in lipopolysaccharide-treated macrophages

机译:羊肚菌多糖对脂多糖处理的巨噬细胞中一氧化氮产生的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Morchella conica is a species of rare edible mushroom whose multiple medicinal functions have been proven. However, reports barely mention the mechanisms of these functions. In this study, the effects of two polysaccharides from M. conica (PMCs) on nitric oxide (NO) production in lipopolysaccharide (LPS)-treated macrophages were investigated. The results showed that 50-200 μg/ml of the extracellular polysaccharide (EPMC) and 25-200 μg/ml of the intracellular polysaccharide (IPMC) significantly inhibited NO production. Accordingly, the signal mechanisms were also explored. It was found that 100 μg/ml of EPMC and 25 μg/ml of IPMC could efficiently down-regulate the inducible nitric oxide synthase (iNOS) expression and nuclear factor-κB (NF-κB) DNAbinding activity and up-regulate heme oxygenase 1 (HO-1) expression. Moreover, by using a HO-1 inhibitor NaPP to treat the cells, the PMC-inhibited NO production and iNOS expression, rather than NF-κB activation, were released partially, indicating that HO-1 probably medicates the inhibition of PMCs on iNOS and NO. Besides, EPMC also significantly suppressed the phosphorylation of p38 mitogen-activated protein kinase (p38), c-jun N-terminal kinase, mitogen-activated protein kinase kinase 4, and expression of NF-κB inducing kinase, while IPMC seemed to show no regular effect on p38. In conclusion, PMCs inhibited NO production in LPS-induced macrophages through regulating a series of signal pathways, suggesting that PMCs play a potential role on immunomodulation and treating related diseases.
机译:羊肚菌是一种稀有的食用菌,其多种医学功能已被证明。但是,报告几乎没有提及这些功能的机制。在这项研究中,研究了来自圆锥角锥菌(PMCs)的两种多糖对脂多糖(LPS)处理的巨噬细胞中一氧化氮(NO)产生的影响。结果表明,50-200μg/ ml的细胞外多糖(EPMC)和25-200μg/ ml的细胞内多糖(IPMC)显着抑制NO的产生。因此,还探讨了信号机制。发现100μg/ ml的EPMC和25μg/ ml的IPMC可以有效下调诱导型一氧化氮合酶(iNOS)的表达和核因子-κB(NF-κB)DNA结合活性,并上调血红素加氧酶1 (HO-1)表达。此外,通过使用HO-1抑制剂NaPP处理细胞,部分释放了PMC抑制的NO生成和iNOS表达,而不是NF-κB活化,这表明HO-1可能有助于抑制PMC对iNOS和iNOS的抑制作用。没有。此外,EPMC还可以显着抑制p38丝裂原活化蛋白激酶(p38),c-jun N端激酶,丝裂原活化蛋白激酶4的磷酸化以及NF-κB诱导激酶的表达,而IPMC则没有显示对p38有规律的影响。总之,PMC通过调节一系列信号通路来抑制LPS诱导的巨噬细胞中NO的产生,这表明PMC在免疫调节和治疗相关疾病中具有潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号